Peripheral Neuropathy Workup

Peripheral neuropathy is one of the most common neurological disorders encountered in clinical practice, yet its evaluation can be daunting due to the sheer number of potential causes. An effective workup is not a random search but a systematic, hypothesis-driven process that efficiently narrows the differential diagnosis. This systematic approach, combining a meticulous clinical examination with targeted diagnostic testing, is crucial for identifying treatable conditions and preventing irreversible nerve damage.

The Foundation: Clinical History and Neurological Examination

The workup for peripheral neuropathy begins long before any test is ordered; it starts with a detailed clinical history and physical examination. This step is critical for framing the entire diagnostic investigation. You must characterize the neuropathy—a dysfunction of the peripheral nerves—by its pattern, timing, and fiber type involvement. Is it symmetric or asymmetric? Did it begin in the feet and ascend (a length-dependent pattern), or did it start in multiple focal areas? Did symptoms develop over days, weeks, or years?

The neurological examination refines these observations. Testing pinprick and temperature sensation assesses small fiber function, while vibration and proprioception tests evaluate large fiber involvement. Motor examination looks for weakness, atrophy, and fasciculations. Deep tendon reflexes are often diminished or absent. This clinical picture allows you to classify the neuropathy broadly: as a symmetric polyneuropathy (most common), a mononeuropathy (single nerve), mononeuritis multiplex (multiple individual nerves), or a radiculopathy (nerve root).

Electrodiagnostic Testing: Nerve Conduction Studies and EMG

When clinical findings suggest neuropathy, electrodiagnostic testing, comprising nerve conduction studies (NCS) and needle electromyography (EMG), is the cornerstone of objective confirmation and characterization. NCS assesses the functional integrity of sensory and motor nerves. A stimulating electrode delivers a small electrical impulse to a nerve, and recording electrodes measure the speed (conduction velocity) and size (amplitude) of the resulting response. Slowed conduction velocities typically indicate demyelination (damage to the myelin sheath), while low response amplitudes suggest axonal loss (damage to the nerve fiber itself).

Electromyography complements NCS by evaluating the electrical activity of muscles at rest and during contraction. It directly assesses for evidence of denervation, such as fibrillations and positive sharp waves, which indicate that a muscle has lost its nerve supply. The pattern of which muscles are affected helps distinguish a primary nerve disorder from a muscle disease or a disorder of the nerve root. Together, NCS and EMG can confirm the presence of neuropathy, localize the lesion, determine if it is primarily axonal or demyelinating, and assess its severity and chronicity.

The Targeted Laboratory Workup

With the clinical and electrodiagnostic profile established, the laboratory workup becomes a targeted search for etiology rather than a indiscriminate panel. For the common symmetric, length-dependent, axonal polyneuropathy, a focused initial screen is recommended. This virtually always includes tests for diabetes mellitus (hemoglobin A1c) and vitamin B12 deficiency, two of the most prevalent causes. The screen is expanded based on clinical clues: for instance, a rapidly progressive neuropathy might prompt testing for autoimmune conditions like Sjögren's syndrome (SSA/SSB antibodies) or vasculitis (ANCA, ESR, CRP).

Other common targets in the initial workup include thyroid function tests, serum protein electrophoresis (for monoclonal gammopathies), and renal function tests. The presence of a demyelinating pattern on NCS drastically changes the differential, shifting focus toward chronic inflammatory demyelinating polyneuropathy (CIDP), which requires specific tests like cerebrospinal fluid analysis for elevated protein. The goal is to identify the 20-30% of neuropathies with a specifically treatable cause.

Advanced and Supportive Diagnostics: Biopsy and Imaging

In most cases, the combination of history, exam, electrodiagnostics, and labs yields a diagnosis. However, when the cause remains elusive or a specific diagnosis requires tissue confirmation, advanced procedures are considered. A nerve biopsy, most often of the sural nerve, is occasionally performed. It provides definitive histopathological diagnosis for conditions like vasculitic neuropathy (showing inflammation of blood vessel walls) and amyloid neuropathy (showing deposits of amyloid protein). Due to its invasive nature and potential for permanent sensory loss, it is reserved for specific clinical scenarios where the results will directly alter management.

Supportive diagnostics include skin biopsy for quantifying intraepidermal nerve fiber density, which is the gold standard for diagnosing pure small fiber neuropathies that are normal on NCS and EMG. Autonomic testing can evaluate involvement of the autonomic nervous system. Imaging studies like MRI of the spine are used not to diagnose generalized polyneuropathy, but to rule out structural causes like radiculopathies, plexopathies, or compressive lesions when the clinical pattern is focal.

Common Pitfalls

1. Skipping the Detailed History and Exam: Jumping straight to an "EMG" or a massive lab panel without a clinical framework is inefficient and often misleading. The pattern of weakness and sensory loss guides all subsequent testing. A patient with isolated hand numbness may have carpal tunnel syndrome, not a generalized polyneuropathy requiring a systemic workup.
2. Misinterpreting Electrodiagnostic Findings: It's a mistake to treat NCS/EMG as a simple "positive/negative" test. The results must be interpreted in the clinical context. Mild, age-appropriate changes in an asymptomatic older adult are not necessarily significant. Conversely, a normal EMG does not rule out a pure small fiber neuropathy.
3. Overlooking Treatable Metabolic Causes: Ordering esoteric autoantibody panels before checking a hemoglobin A1c or B12 level is a common error. Diabetes and B12 deficiency are extremely common and highly treatable; they must be ruled out in every initial evaluation for symmetric polyneuropathy.
4. Over-reliance on Nerve Biopsy: Biopsy is not a routine screening tool. It has the highest diagnostic yield in asymmetric, painful neuropathies where vasculitis or amyloidosis is suspected. Using it for a typical diabetic neuropathy is inappropriate and exposes the patient to unnecessary risk.

Summary

• The peripheral neuropathy workup is a staged, logical process that begins with a thorough clinical assessment to define the neuropathy's pattern, timing, and fiber type involvement.
• Electrodiagnostic testing (NCS and EMG) is the key objective test to confirm the diagnosis, differentiate axonal from demyelinating pathology, and localize the lesion.
• The laboratory evaluation is targeted, not exhaustive, with screening for diabetes and B12 deficiency as universal first steps, followed by testing for autoimmune, toxic, or metabolic causes based on clinical and electrodiagnostic clues.
• Nerve biopsy is a specialized tool reserved for specific diagnostic questions, most notably suspected vasculitic or amyloid neuropathies, and is not part of the routine workup.
• The overarching goal is to identify the subset of neuropathies with specific, treatable causes to prevent progression and manage symptoms effectively.